GD
About
GenDx develops and markets a comprehensive line of In Vitro Diagnostic (IVD) tests and services, analysis software and education. The company is a pioneer in the area of Sequencing-Based Typing (SBT) for transplantation offering high resolution HLA typing methods for Sanger and NGS techniques.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 113 investors are based in Utrecht, Utrecht, The Netherlands.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech biotech saas
- Location
- Utrecht, The Netherlands
Contact Information
Find more investors like Genome
Search Investors